Molecular hydrogen (H2 ) as a potential treatment for acute and chronic fatigue

Arch Pharm (Weinheim). 2021 Apr;354(4):e2000378. doi: 10.1002/ardp.202000378. Epub 2020 Dec 23.

Abstract

Many diseases as well as acute conditions can lead to fatigue, which can be either temporary or chronic in nature. Acute fatigue develops frequently after physical exercise or after alcohol hangover, whereas microbial infections such as influenza or COVID-19 and chronic diseases like Parkinson's disease or multiple sclerosis are often associated with chronic fatigue. Oxidative stress and a resulting disturbance of mitochondrial function are likely to be common denominators for many forms of fatigue, and antioxidant treatments have been shown to be effective in alleviating the symptoms of fatigue. In this study, we review the role of reactive oxygen and nitrogen species in fatigue and the antioxidant effects of the intake of molecular hydrogen. We propose that molecular hydrogen is well suited for the treatment of temporary and chronic forms of oxidative stress-associated fatigue.

Keywords: COVID-19; acute fatigue; chronic fatigue; hydrogen; inflammation; oxidative stress.

MeSH terms

  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • COVID-19* / metabolism
  • COVID-19* / physiopathology
  • Fatigue* / etiology
  • Fatigue* / metabolism
  • Fatigue* / therapy
  • Humans
  • Hydrogen* / metabolism
  • Hydrogen* / pharmacology
  • Nitrogen
  • Oxidative Stress* / drug effects
  • Oxidative Stress* / physiology
  • Quantitative Structure-Activity Relationship
  • Reactive Oxygen Species
  • SARS-CoV-2

Substances

  • Antioxidants
  • Reactive Oxygen Species
  • Hydrogen
  • Nitrogen